| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/06/2002 | EP1176931A1 Intrauterine contraceptive device |
| 02/06/2002 | EP1052987B1 Tablets to be crunched or sucked, comprising iron as active principle |
| 02/06/2002 | EP1001773B1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 02/06/2002 | EP0912501B1 Per(poly)fluorinated polyoxyethylated carbamates |
| 02/06/2002 | EP0878198B1 Tablets containing an anion exchange resin |
| 02/06/2002 | EP0815868B1 A chinese drug composition for treatment of peptic ulcer |
| 02/06/2002 | EP0800392B1 Pharmaceutical preparations containing nifedipine and process for producing it |
| 02/06/2002 | EP0776663B1 Remedy for myotonic dystrophy |
| 02/06/2002 | EP0764028B1 Method of treating retained pulmonary secretions |
| 02/06/2002 | EP0731694B1 Opioid formulations for treating pain |
| 02/06/2002 | EP0729353B1 Preparation of biodegradable microparticles containing a biologically active agent |
| 02/06/2002 | EP0679081B1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/06/2002 | CN2475402Y Built-in anus therapeutic suppository |
| 02/06/2002 | CN1334881A Method of drying lactulose solution |
| 02/06/2002 | CN1334834A Process for producing polymer |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334744A Medicinal aerosol formulation |
| 02/06/2002 | CN1334743A Method for accelerating rate of mucociliary clearance |
| 02/06/2002 | CN1334738A Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 02/06/2002 | CN1334737A Aciclovir compositions contg. dimethicone |
| 02/06/2002 | CN1334731A Pharmaceutical formulation |
| 02/06/2002 | CN1334729A Controlled-release dosage forms comprising zolpidem or salt thereof |
| 02/06/2002 | CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 02/06/2002 | CN1334725A Parenteral solution of propofol (2,6-diisopropylphenol) and 2,5-di-O-methyl-1,4;3,6-dianhydro-D-glucitol as solvent |
| 02/06/2002 | CN1334724A Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations |
| 02/06/2002 | CN1334723A Improvements in or relating to powder |
| 02/06/2002 | CN1334720A Cosmetic skin care compositions contg 4-chromanone |
| 02/06/2002 | CN1334702A Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/06/2002 | CN1334285A Polysaccharide material for direct tabletting |
| 02/06/2002 | CN1334119A Litholysizing bear gall powder |
| 02/06/2002 | CN1334116A Soft vinegar capsule |
| 02/06/2002 | CN1334110A Chinese medicine for treating blood viscosity and its preparing process |
| 02/06/2002 | CN1334105A 'Bingshe' antalgesic plaster |
| 02/06/2002 | CN1334095A Concentrated acanthopanax bark particles and its preparing process |
| 02/06/2002 | CN1334083A Nitroimiazoles colon target medicine and its preparing process |
| 02/06/2002 | CN1334082A Chinese-medical suppository for treating vaginal looseness |
| 02/06/2002 | CN1334080A Slow-release wanlafacine hydrochloride tablet and its preparing process |
| 02/06/2002 | CN1334079A Far-infrared medicinal pitch for treating rheumatism, promoting blood circulation, relieving inflammation and relaxing pain and its preparing process |
| 02/06/2002 | CN1078815C Microparticle agent made of biological degradable copolymer |
| 02/06/2002 | CN1078814C Pill for treating diabetes mellitus |
| 02/05/2002 | WO2002034268A1 Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2-[2-[4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient |
| 02/05/2002 | US6344576 Phospholipid-analogous compounds |
| 02/05/2002 | US6344490 Removable filter for slurry hydrocarbon synthesis process |
| 02/05/2002 | US6344489 Without bubbles |
| 02/05/2002 | US6344488 Temperature-controlled pH-dependent formation of ionic polysaccharide gels |
| 02/05/2002 | US6344480 Oral analgesic compositions |
| 02/05/2002 | US6344479 Amino acid salt of ibuprofen |
| 02/05/2002 | US6344478 Mixture with carbonic anhydrase inhibitor |
| 02/05/2002 | US6344475 Cystic fibrosis |
| 02/05/2002 | US6344446 Gene delivery |
| 02/05/2002 | US6344438 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 02/05/2002 | US6344437 Medicine drink food and feed having an action of strengthening bone |
| 02/05/2002 | US6344271 Materials and products using nanostructured non-stoichiometric substances |
| 02/05/2002 | US6344222 Nicotine, hydrophilic and hydrophobic polymer, buffer; time-relese agents |
| 02/05/2002 | US6344219 Oils of chenopodium ambrosiodes and adina pilulifera that inhibit pyloric spirillum |
| 02/05/2002 | US6344216 Conversion of powdered polymers |
| 02/05/2002 | US6344215 Methylphenidate modified release formulations |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/05/2002 | US6344212 Method of providing sustained analgesia with buprenorphine |
| 02/05/2002 | US6344211 Releasing drugs to skin having absorption-increasing auxiliary agents; antibiotics, antipyretics, analgesics, anticoagulants, antidiabetic, cardiotonic, antispasmodic, hypotensive, anticholinergenic, antyarrthythmic agents |
| 02/05/2002 | US6344210 Composition for freshening nostrils and sinus cavities |
| 02/05/2002 | US6344209 Apatite-coated solid composition |
| 02/05/2002 | US6344194 Dissolving a virus in an aqueous solution containing 6-12 g/l of a monovalent cation salt (such as nacl or kcl), or 50-100 g/l of a hexose and atomizing |
| 02/05/2002 | US6344189 Topical administration of a serine protease inhibitor, such as pai-2. |
| 02/05/2002 | US6344187 Heating the composition including a wax to at least partially melt the wax; blending the remaining constituents while cooling |
| 02/05/2002 | US6344182 Preparation of diagnostic agents by spray drying |
| 02/05/2002 | US6343602 Method of and a device for dry application of substances on inhalable pulverulent carrier substances |
| 02/05/2002 | CA2242552C A process for preparing a controlled release composition |
| 02/05/2002 | CA2222161C Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
| 02/05/2002 | CA2219940C Method of producing products from polymer materials having a medicamentous depot effect |
| 02/05/2002 | CA2150464C A pharmaceutical formulation for intraduodenal administration |
| 02/05/2002 | CA2110290C Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 02/05/2002 | CA2050623C Ointments containing tricyclic compound |
| 02/05/2002 | CA2045290C Plaster with a high content of softening ingredients |
| 02/03/2002 | CA2353364A1 Aerosol for the treatment or prevention of pain |
| 01/31/2002 | WO2002008470A1 Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| 01/31/2002 | WO2002008352A1 Medical contact adhesive comprising a two phase adhesive matrix of polyacrylates and polyamine salts |
| 01/31/2002 | WO2002008182A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 01/31/2002 | WO2002007813A1 Vaccines |
| 01/31/2002 | WO2002007772A2 Improved oral dosage formulations |
| 01/31/2002 | WO2002007769A1 A method of stabilisation and compositions for use therein |
| 01/31/2002 | WO2002007767A2 Pharmaceutical suspension compositions lacking a polymeric suspending agent |
| 01/31/2002 | WO2002007752A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 01/31/2002 | WO2002007745A1 Antipruritic compositions and compositions promoting wound healing |
| 01/31/2002 | WO2002007738A1 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 01/31/2002 | WO2002007736A1 The process for manufacturing of clear liquid pharmaceutical composition of azithromycin |
| 01/31/2002 | WO2002007724A1 FREEZE-DRIED PREPARATION OF N-[o-(p-PIVALOYLOXYBENZENESULFONYLAMINO)BENZOYL]GLYCINE MONOSODIUM SALT TETRAHYDRATE AND PROCESS FOR PRODUCING THE SAME |
| 01/31/2002 | WO2002007723A1 Compositions for regulating desire for smoking |
| 01/31/2002 | WO2002007719A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 01/31/2002 | WO2002007717A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 01/31/2002 | WO2002007715A2 A method for treating celiac disease |
| 01/31/2002 | WO2002007712A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 01/31/2002 | WO2002007711A1 Compositions and films for capsule manufacture |
| 01/31/2002 | WO2002007710A2 Delivery device |
| 01/31/2002 | WO2002007709A1 Antiviral pharmaceutical compositions containing iron chelators |
| 01/31/2002 | WO2002007708A1 Lyophilized powder of lentinan and the process of preparation thereof |
| 01/31/2002 | WO2002007707A2 Linkage of agents using microparticles |
| 01/31/2002 | WO2002007706A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
| 01/31/2002 | WO2002007705A1 Carrier material for dry powder inhalation |
| 01/31/2002 | WO2002007704A2 Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |